Product List     API & Intermediate     

Inhibitors

Find
147
related chemicals for you
CAS:58579-51-4
Molecular Formula:C10H8Cl3N3O
Anagrelide HCL; Agrylin; Agrelin; Thromboreductin; Xagrid; Anagrelide (Hydrochloride); Anagrelid Hydrochlorid; 6,7-Dichloro-5,10-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride; Anagrelide Hydrochloride Hydrate; Xagrid (TN); Imidazo(2,1-b)Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)Quinazolin-2(3H)-one Hydrochloride; 6,7-Dichloro-3,5-Dihydro-1H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one;Hydrochloride; C10H7Cl2N3O.ClH; Imidazo[2,1-b]Quinazolin-2(3H)-one, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride; Anagrelide Hydrocholoride; C10H7Cl2N3O.HCl; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride (USP); Anagrelide Hydrochloride- Bio-X; 6,7-Dichloro-1H,2H,3H,5H-Imidazolidino[2,1-b]Quinazolin-2-one Hydrochloride; Anagrelide Hydrochloride Anhydrous; Imidazo[2,6,7-Dichloro-1,5-Dihydro-, Monochloride; 6,7-Dichloro-5,10-Dihydro-3H-Imidazo[2,1-b]Quinazolin-2-one HCl; 6,7-Dichloro-2H,3H,5H,10H-Imidazo[2,1-b]Quinazolin-2-one Hydrochloride; 6,7-Dichloro-3,5-Dihydroimidazo[2,1-b]Quinazolin-2(1H)-one Hydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-.BETA.)-Quinazolin-2(3H)-ONE Monohydrochloride; 6,7-Dichloro-1,5-Dihydroimidazo(2,1-b)-Quinazolin-2(3H)-one Monohydrochloride ; 6,7-Dichloro-1,5-Dihydroimidazo[2,1-b]Quinazolin-2(3H)-one Monohydrochloride;Anagrelide Hydrochloride; Imidazo(2,1-.BETA.)Quinazolin-2(3H)-ONE, 6,7-Dichloro-1,5-Dihydro-, Monohydrochloride
Brief Introduction
Anagrelide Hydrochloride is a phosphodiesterase inhibitor with antiplatelet activity. Used as an antithrombocythemic.
CAS:827022-33-3
Molecular Formula:C26H35N7O6S
PD0332991 Isethionate; PD 0332991 Isethionate; Palbociclib (PD0332991) Isethionate; Palbociclib (Isethionate); 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethanesulfonate; 6-Acetyl-8-Cyclopentyl-5-Methyl-2-((5-(Piperazin-1-yl)Pyridin-2-yl)Amino)Pyrido[2,3-d]Pyrimidin-7(8H)-one 2-Hydroxyethane-1-Sulfonate
Brief Introduction
PD 0332991 Isethionate is a selective inhibitor of cyclin dependant kinases CDK4 and CDK6 used in the treatment of cancer patients.
CAS:841205-47-8
Molecular Formula:C19H14F3N3O3
Ostarine; GTx-024; MK-2866; MK-2866(Ostarine); SARM; (2S)-3-(4-Cyanophenoxy)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-2-Hydroxy-2-Methylpropanamide; (S)-N-(4-Cyano-3-(Trifluoromethyl)Phenyl)-3-(4-Cyanophenoxy)-2-Hydroxy-2-Methylpropanamide; Ostarine(MK-2866); MK 2866
Brief Introduction
Ostarine (GTx-024, MK-2866) is a selective androgen receptor modulator (SARM) (selective androgen receptor modulator) with Ki of 3.8 nM, which is tissue selective for anabolic organs.
CAS:915087-33-1
Molecular Formula:C21H16F4N4O2S
Mdv 3100; Xtandi; Unii-93T0T9Gknu; [14C]-Enzalutamide; N-Methyl-4-[3-(4-Cyano-3-Trifluoromethylphenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl]-2-Fluorobenzamide; 4-(3-(4-Cyano-3-(Trifluoromethyl)Phenyl)-5,5-Dimethyl-4-Oxo-2-Thioxoimidazolidin-1-Yl)-2-Fluoro-N-Methylbenzamide
Brief Introduction
Enzalutamide is an oral androgen receptor antagonist. At present, it has been approved by clinical research and FDA (food and Drug Administration) for the treatment of metastatic castration tolerant prostate cancer after chemotherapy (i.e. such patients with prostate cancer whose tumor or cancer cells are still growing after chemotherapy), which can prolong the survival time of patients.
CAS:923564-51-6
Molecular Formula:C47H55ClF3N5O6S3
Navitoclax; ABT 263; ABT263; (R)-4-(4-((4'-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro-[1,1'-Biphenyl]-2-yl)Methyl)Piperazin-1-yl)-N-((4-((4-Morpholino-1-(Phenylthio)Butan-2-yl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-Morpholinyl)-1-[(Phenylthio)Methyl]Propyl]Amino]-3-[(Trifluoromethyl)Sulfonyl]Phenyl]Sulfonyl]Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethylcyclohexen-1-yl]Methyl]Piperazin-1-yl]-N-[4-[[(2R)-4-Morpholin-4-yl-1-Phenylsulfanylbutan-2-yl]Amino]-3-(Trifluoromethylsulfonyl)Phenyl]Sulfonylbenzamide; (R)-4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-enyl)Methyl)Piperazin-1-yl)-N-(4-(4-Morpholino-1-(Phenylthio)Butan-2-Ylamino)-3-(Trifluoromethylsulfonyl)p; (R)-4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-enyl)Methyl)Piperazin-1-yl)-N-(4-(4-Morpholino-1-(Phenylthio)Butan-2-Ylamino)-3-(Trifluoromethylsulfonyl)Phenylsulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-en-1-yl]Methyl}Piperazin-1-yl)-N-({4-({(1R)-3-Morpholin-4-yl-1-[(Phenylsulfanyl)Methyl]Propyl}Amino)-3-[(Trifluoromethyl)Sulfonyl]Phenyl}Sulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-En-1-Yl]Methyl}Piperazin-1-Yl)-N-[(4-{[(2r)-4-(Morpholin-4-Yl)-1-(Phenylsulfanyl)Butan-2-Yl]Amino}-3-[(Trifluoromethyl)Sulfonyl]Phenyl)Sulfonyl]Benzamide; Navitoclaxum; C47H55ClF3N5O6S3; 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-EN-1-YL)Methyl)Piperazin-1-YL)-N-((4-(((2R)-4-(Morpholin-4-YL)-1-(Phenylsulfanyl)Butan-2-YL)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; ABT-263,Navitoclax; ABT-263 In Bulk; Navitoclax, ABT-263; ABT-263 - Navitoclax; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-mo; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-Cyclohexen-1-yl]Methyl]Piperazin-1-yl]-N-[4-[[(1R)-3-Morpholino-1-(Phenylsulfanylmethyl)Propyl]Amino]-3-(Trifluoromethylsulfonyl)Phenyl]Sulfonyl-Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimet; (R)-4-(4-((4-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro-[1,1-Biphenyl]-2-yl)Methyl)Piperazin-1-yl)-N-((4-((4-Morpholino-1-(Phenylthio)Butan-2-yl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)Benzamide; 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-EN-1-YL)Methyl)Piperazin-1-YL)-N-(4-(((2R)-4-(Morpholin-4-YL)-1-(Phenylsulfanyl)Butan-2-YL)Amino)-3-(Trifluoromethanesulfonyl)Benzenesulfonyl)Benzamide; 4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-en-1-yl]Methyl}Piperazin-1-yl)-N-({4-({(1R)-3-(Morpholin-4-yl)-1-[(Phenylsulfanyl)Methyl]Propyl}Amino)-3-[(Trifluoromethyl)Sulfonyl]Phenyl}Sulfonyl)Benzamide; 4-[4-[[2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl]Methyl]-1-Piperazinyl]-N-[[4-[[(1R)-3-(4-Morpholinyl)-1-[(Phenylthio)Methyl]Propyl]Amino]-3-[(Trifluoromethyl)Sulfonyl]Phenyl]Sulfonyl]Benzamide;ABT 263;Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-dime; 4-{4-[(4'-Chloro-4,4-Dimethyl-3,4,5,6-Tetrahydro[Biphenyl]-2-yl)Methyl]Piperazin-1-yl}-N-[(4-{[(2R)-4-(Morpholin-4-yl)-1-(Phenylsulfanyl)Butan-2-yl]Amino}-3-[(Trifluoromethyl)Sulfonyl]Phenyl)Sulfonyl]Benzamide; Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-YL)Methyl)-1- Piperazinyl)-N-((4-(((1R)-3-(4-Morpholinyl)-1-((Phenylthio)Methyl)Propyl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)-; Benzamide, 4-(4-((2-(4-Chlorophenyl)-5,5-Dimethyl-1-Cyclohexen-1-yl)Methyl)-1-Piperazinyl)-N-((4-(((1R)-3-(4-Morpholinyl)-1-((Phenylthio)Methyl)Propyl)Amino)-3-((Trifluoromethyl)Sulfonyl)Phenyl)Sulfonyl)-; N-(4-{4-[2-(4-Chlorophenyl)-5,5-Dimethyl-Cyclohex-1-Enylmethyl]-Piperazin-1-yl}-Benzoyl)-4-((r)-3-Morpholin-4-yl-1-Phenylsulfanylmethyl-Propylamino)-3-Trifluoromethanesulfonyl-Benzenesulfonamide
Brief Introduction
ABT 263 is a new inhibitor of the anti-apoptotic BCL-2 protein; a promising new drug against cancer. It is a potent Bcl-2 family inhibitor.
Inquiry ( 
10
 
/ 10
 )
Clear All
Sign In
Please enter your email address correctly
Please enter your password
Forgot Password
OR
Join Free >